These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9233759)
1. P53 associates with trk tyrosine kinase. Montano X Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759 [TBL] [Abstract][Full Text] [Related]
2. Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis. Jiang H; Movsesyan V; Fink DW; Fasler M; Whalin M; Katagiri Y; Monshipouri M; Dickens G; Lelkes PI; Guroff G; Lazarovici P J Cell Biochem; 1997 Aug; 66(2):229-44. PubMed ID: 9213224 [TBL] [Abstract][Full Text] [Related]
3. c-abl is involved in the association of p53 and trk A. Brown A; Browes C; Mitchell M; Montano X Oncogene; 2000 Jun; 19(26):3032-40. PubMed ID: 10871855 [TBL] [Abstract][Full Text] [Related]
4. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene. Colangelo AM; Fink DW; Rabin SJ; Mocchetti I Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines. Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209 [TBL] [Abstract][Full Text] [Related]
6. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule. Albor A; Thraves PJ; Dritschilo A; Notario V Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522 [TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048 [TBL] [Abstract][Full Text] [Related]
9. Expression of TRK-T1 oncogene induces differentiation of PC12 cells. Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Kaplan DR; Martin-Zanca D; Parada LF Nature; 1991 Mar; 350(6314):158-60. PubMed ID: 1706478 [TBL] [Abstract][Full Text] [Related]
12. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation. Montano X Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791 [TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Mutoh T; Tokuda A; Miyadai T; Hamaguchi M; Fujiki N Proc Natl Acad Sci U S A; 1995 May; 92(11):5087-91. PubMed ID: 7539142 [TBL] [Abstract][Full Text] [Related]
14. p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels. Zhang J; Yan W; Chen X Cell Death Differ; 2006 Dec; 13(12):2118-28. PubMed ID: 16729028 [TBL] [Abstract][Full Text] [Related]
16. Regulation of NGF responsiveness in human neuroblastoma. Bogenmann E; Peterson S; Maekawa K; Matsushima H Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468 [TBL] [Abstract][Full Text] [Related]
17. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth. Ashcroft M; Stephens RM; Hallberg B; Downward J; Kaplan DR Oncogene; 1999 Aug; 18(32):4586-97. PubMed ID: 10467403 [TBL] [Abstract][Full Text] [Related]